FI66623C - Molekylkoordinationskomplex och foerfarande foer dess framstaellning - Google Patents

Molekylkoordinationskomplex och foerfarande foer dess framstaellning Download PDF

Info

Publication number
FI66623C
FI66623C FI803848A FI803848A FI66623C FI 66623 C FI66623 C FI 66623C FI 803848 A FI803848 A FI 803848A FI 803848 A FI803848 A FI 803848A FI 66623 C FI66623 C FI 66623C
Authority
FI
Finland
Prior art keywords
polymer
alcohol
weight
cellulose
cellulosic polymer
Prior art date
Application number
FI803848A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI66623B (fi
FI803848L (fi
Inventor
Stewart Thomas Leslie
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of FI803848L publication Critical patent/FI803848L/fi
Application granted granted Critical
Publication of FI66623B publication Critical patent/FI66623B/fi
Publication of FI66623C publication Critical patent/FI66623C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00Preparation of cellulose ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/05Alcohols; Metal alcoholates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
FI803848A 1979-12-19 1980-12-10 Molekylkoordinationskomplex och foerfarande foer dess framstaellning FI66623C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IE2480/79A IE49324B1 (en) 1979-12-19 1979-12-19 Controlled release compositions
IE248079 1979-12-19
IE248179 1979-12-19
IE248179 1979-12-19

Publications (3)

Publication Number Publication Date
FI803848L FI803848L (fi) 1981-06-20
FI66623B FI66623B (fi) 1984-07-31
FI66623C true FI66623C (fi) 1984-11-12

Family

ID=26319271

Family Applications (1)

Application Number Title Priority Date Filing Date
FI803848A FI66623C (fi) 1979-12-19 1980-12-10 Molekylkoordinationskomplex och foerfarande foer dess framstaellning

Country Status (27)

Country Link
US (1) US4366310A (xx)
EP (1) EP0032004B1 (xx)
JP (1) JPS5698201A (xx)
AU (1) AU541246B2 (xx)
BE (1) BE886711A (xx)
CA (1) CA1168230A (xx)
CS (1) CS228142B2 (xx)
DE (1) DE3048028A1 (xx)
DK (1) DK170347B1 (xx)
EG (1) EG14984A (xx)
ES (1) ES497906A0 (xx)
FI (1) FI66623C (xx)
FR (1) FR2474507B1 (xx)
GB (1) GB2067569B (xx)
GR (1) GR72265B (xx)
HU (1) HU188085B (xx)
IE (1) IE49324B1 (xx)
IL (1) IL61677A (xx)
MX (1) MX158088A (xx)
NL (1) NL187401C (xx)
NO (1) NO152846C (xx)
NZ (1) NZ195793A (xx)
PL (1) PL133079B1 (xx)
PT (1) PT72214B (xx)
SU (1) SU1178326A3 (xx)
YU (1) YU40957B (xx)
ZA (1) ZA807716B (xx)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1211266A (en) * 1982-11-12 1986-09-16 Alfred E. Lauchenauer Shaped semi-solid articles
DE3306621A1 (de) * 1983-02-25 1984-08-30 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von celluloseethern mit einem dimethoxyethan enthaltenden dispergierhilfsmittel
GB8514665D0 (en) * 1985-06-11 1985-07-10 Eroceltique Sa Oral pharmaceutical composition
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
ES2058111T3 (es) * 1986-06-10 1994-11-01 Euro Celtique Sa Composicion de liberacion controlada de dihidrocodeina.
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
US5079005A (en) * 1988-06-17 1992-01-07 Gupta Kashmiri L Time release protein
US5055300A (en) * 1988-06-17 1991-10-08 Basic Bio Systems, Inc. Time release protein
US5023080A (en) * 1988-06-17 1991-06-11 Basic Bio Systems, Inc. Time release protein
US5476668A (en) * 1990-08-24 1995-12-19 Shin-Etsu Chemical Co., Ltd. Base for film-coating pharmaceuticals and method for preparing same
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
AU8532798A (en) * 1997-06-13 1998-12-30 Roland Bodmeier Compounds which delay the release of active substances
PT1041987E (pt) 1997-12-22 2006-07-31 Euro Celtique Sa Forma farmaceutica de dosagem oral, compreendendo uma combinacao de um agonista de opioide e naltrexona
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
RS50407B (sr) 2000-02-08 2009-12-31 Euro-Celtique S.A., Oralne formulacije opijatnog agonista otporne na mehaničke,termičke i/ili hemijske promene fizičkih osobina doznog oblika
EP1387673B1 (en) 2001-05-11 2010-12-29 Endo Pharmaceuticals Inc. Abuse-resistant controlled-release opioid dosage form
DK1416842T3 (da) 2001-07-18 2009-03-16 Euro Celtique Sa Farmaceutiske kombinationer af oxycodon og naloxon
US20030044458A1 (en) 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
AU2002324624A1 (en) 2001-08-06 2003-02-24 Euro-Celtique S.A. Sequestered antagonist formulations
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
PL367427A1 (en) 2001-08-06 2005-02-21 Euro-Celtique S.A. Opioid agonist formulations with releasable and sequestered antagonist
DE60325567D1 (de) 2002-04-05 2009-02-12 Euro Celtique Sa Matrix für die modifizierte freigabe von aktiven substanzen
PT1551372T (pt) 2002-09-20 2018-07-23 Alpharma Pharmaceuticals Llc Subunidade de sequestração e composições e métodos relacionados
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
TWI347201B (en) 2003-04-21 2011-08-21 Euro Celtique Sa Pharmaceutical products,uses thereof and methods for preparing the same
EP1604666A1 (en) 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
LT1765292T (lt) 2004-06-12 2018-01-10 Collegium Pharmaceutical, Inc. Nuo piktnaudžiavimo apsaugotos vaistų formos
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
ES2600141T3 (es) 2006-06-19 2017-02-07 Alpharma Pharmaceuticals Llc Composiciones farmacéuticas
EP1897543A1 (en) 2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine- wafer for drug substitution therapy
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
JP2010159364A (ja) * 2009-01-09 2010-07-22 Kyoto Univ セルロースの高温での着色を抑制する方法
CN102387802B (zh) 2009-03-10 2016-05-04 欧洲凯尔特公司 包含羟考酮和纳洛酮的立即释放药物组合物
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
BR112012028656A2 (pt) 2010-05-10 2016-08-09 Euro Celtique Sa combinação de grânulos carregados ativos com ativos adicionais
NZ603173A (en) * 2010-05-10 2014-10-31 Euro Celtique Sa Manufacturing of active-free granules and tablets comprising the same
MY157673A (en) 2010-05-10 2016-07-15 Euro Celtique Sa Pharmaceutical compositions comprising hydromorphone and naloxone
CN103370058A (zh) 2010-12-22 2013-10-23 普渡制药公司 包覆的抗篡改控制释放剂型
KR101458334B1 (ko) 2010-12-23 2014-11-04 퍼듀 퍼머 엘피 탬퍼 저항성 고체 경구 투여 형태
AP2015008579A0 (en) 2013-02-05 2015-07-31 Purdue Pharma Lp Tamper resistant pharmaceutical formulations
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
NZ716267A (en) 2013-07-23 2017-05-26 Euro Celtique Sa A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
EP3068397A1 (en) 2013-11-13 2016-09-21 Euro-Celtique S.A. Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264766A (en) * 1877-09-19 1981-04-28 Hoffmann-La Roche Inc. Immunological diagnostic reagents
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
US3146167A (en) * 1961-10-05 1964-08-25 Smith Kline French Lab Method of preparing sustained release pellets and products thereof
GB1405088A (en) * 1971-06-03 1975-09-03 Mundipharma Ag Slow release formulation
US3988482A (en) * 1971-08-27 1976-10-26 Toyo Hakka Kogyo Kabushiki Kaisha Menthol glycoside, process for preparing the same and method for releasing menthol therefrom
US3818107A (en) * 1972-09-28 1974-06-18 Brook D Chewing gum with sustained flavor release compositions
US3899439A (en) * 1973-03-12 1975-08-12 Hercules Inc Method of preparing aqueous dispersions of hydroxypropyl cellulose
DE2644678A1 (de) * 1976-10-02 1978-04-06 Dynamit Nobel Ag Verfahren zur herstellung funktionalisierter cellulosen
JPS54105223A (en) * 1977-12-29 1979-08-18 Yamanouchi Pharmaceut Co Ltd Coating agent for solid medicine
US4259355A (en) * 1979-03-05 1981-03-31 International Flavors & Fragrances Inc. Chewing gum containing flavor composition and flavor composition therefor
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals

Also Published As

Publication number Publication date
PT72214B (en) 1981-11-02
JPS5698201A (en) 1981-08-07
ES8303489A1 (es) 1983-02-01
ES497906A0 (es) 1983-02-01
IL61677A (en) 1984-10-31
HU188085B (en) 1986-03-28
EP0032004A2 (en) 1981-07-15
YU321080A (en) 1983-06-30
AU6529880A (en) 1981-06-25
CA1168230A (en) 1984-05-29
AU541246B2 (en) 1985-01-03
GB2067569B (en) 1983-09-01
NL8006891A (nl) 1981-07-16
DK170347B1 (da) 1995-08-07
US4366310A (en) 1982-12-28
HUT34891A (en) 1985-05-28
NO803836L (no) 1981-06-22
CS228142B2 (en) 1984-05-14
EP0032004B1 (en) 1985-05-15
ZA807716B (en) 1981-12-30
FR2474507A1 (fr) 1981-07-31
PL133079B1 (en) 1985-05-31
PT72214A (en) 1980-08-01
YU40957B (en) 1986-08-31
NL187401C (nl) 1991-09-16
DE3048028A1 (de) 1981-09-10
NO152846C (no) 1985-11-27
GR72265B (xx) 1983-10-10
DK527680A (da) 1981-08-05
IE792480L (en) 1981-06-19
GB2067569A (en) 1981-07-30
EG14984A (en) 1986-06-30
JPH0225921B2 (xx) 1990-06-06
NO152846B (no) 1985-08-19
PL228573A1 (xx) 1982-07-19
MX158088A (es) 1989-01-06
NZ195793A (en) 1982-09-14
FI66623B (fi) 1984-07-31
NL187401B (nl) 1991-04-16
SU1178326A3 (ru) 1985-09-07
EP0032004A3 (en) 1982-07-14
IE49324B1 (en) 1985-09-18
FI803848L (fi) 1981-06-20
FR2474507B1 (fr) 1986-12-26
BE886711A (fr) 1981-06-17
IL61677A0 (en) 1981-01-30

Similar Documents

Publication Publication Date Title
FI66623C (fi) Molekylkoordinationskomplex och foerfarande foer dess framstaellning
US4842866A (en) Slow release solid preparation
FI100219B (fi) Menetelmä farmaseuttisen granulaatin valmistamiseksi
US5456921A (en) Use of cross-linked amylose as a matrix for the slow release of biologically active compounds
DE1258548C2 (de) Verfahren zur Herstellung von Arzneimitteltabletten unter Verwendung von Kunstharzen als die Wirkstoffabgabe verzoegernde Einbettungsmassen
EP0559813B1 (en) Controlled release compositions
EP0250374B1 (en) Therapeutic system for controlled release of drugs
CA1079638A (en) Coated granules of polyacrylic alkali metal salts and method of producing same
DE4200188A1 (de) Klebstoff
US3836618A (en) Process for the uniform distribution of a drug on a granulated base
KR0177493B1 (ko) 단사정계 결정구조를 갖고 감열, 감광 및 감습성이 있는 활성성분을 함유하는 정제의 제조방법
DD209575A5 (de) Verfahren zur herstellung eines pharmazeutischen produktes in anhaltend freisetzender form
DE112006001853T5 (de) Pharmazeutische Zusammensetzungen, die Clopidogrel-Bisulphat enthalten
DE4127522A1 (de) Neue masse mit einem hydrophilen polymer und einem davon verschiedenen hydrophilen material
US4218333A (en) Process for the preparation of pharmaceutical substance-containing microcapsules
CN107550881B (zh) 一种非洛地平缓释片及其制备工艺
GB2192128A (en) Production of pharmaceutical unit dosage forms
DE60311796T2 (de) Methode zur verbesserung der oberflächeneigenschaften von tabletten
US4315909A (en) Process for the preparation of solid drug formulations
Makino et al. Importance of gelatinization degree of starch paste binder in hardness and disintegration time of tablets
WAN et al. Action of methylcellulose on disintegration and dissolution properties of tablets
JPS60141694A (ja) 崩壊性粒状苦土肥料及び崩壊性粒状石灰質肥料の製造方法
DE2030501A1 (en) Retarded release medicaments - with active ingredient embedded in a silicic acid matrix
KR950703947A (ko) 고형 의약용 조성물의 제조방법(method of manufacturing composition for solid medicine)

Legal Events

Date Code Title Description
MA Patent expired

Owner name: EURO-CELTIQUE, S.A.